Clindamycin-Resistant Clostridium difficile
- 30 April 2014
- book chapter
- Published by American Society for Microbiology
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- The Macrolide-Lincosamide-Streptogramin B Resistance Determinant from Clostridium difficile 630 Contains Two erm (B) GenesAntimicrobial Agents and Chemotherapy, 2000
- Antimicrobial Susceptibilities and Serogroups of Clinical Strains of Clostridium difficile Isolated in France in 1991 and 1997Antimicrobial Agents and Chemotherapy, 1999
- Risk factors for Clostridium difficile infectionJournal of Hospital Infection, 1998
- Hospital-wide Restriction of Clindamycin: Effect on the Incidence of Clostridium difficile-Associated Diarrhea and CostAnnals of Internal Medicine, 1998
- Characterization of a Nosocomial Clostridium difficile Outbreak by Using Plasmid Profile Typing and Clindamycin Susceptibility TestingThe Journal of Infectious Diseases, 1988
- Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficileJournal of Antimicrobial Chemotherapy, 1988
- In vitro activity of efrotomycin, ciprofloxacin, and six other antimicrobials against Clostridium difficileDiagnostic Microbiology and Infectious Disease, 1987
- In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibioticsAntimicrobial Agents and Chemotherapy, 1985
- In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitisAntimicrobial Agents and Chemotherapy, 1980
- Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in HamstersThe Journal of Infectious Diseases, 1977